|
|
 Suicide Information - August 8, 2008
| Supporters of a doctor-initiated death initiative turned in an estimated 320,000 signatures Tuesday to the Secretary of State's Office. The signatures are more than enough to send Initiative 1000 to voters in November. If approved, Initiative 1000 would allow doctors to prescribe lethal medicines to patients with six months or less to live. Supporters say Initiative 1000 would allow mentally competent, terminally ill adults to request and self-administer medication in order to die on their own terms. The initiative was filed in January by former Gov. Booth Gardner, a Parkinson's disease patient | | Teens who are hooking up with the rising social networking sites face potential dangers, according to a psychiatrist. Psychiatrist Dr. Himanshu Tyagi said that Facebook and MySpace could be dangerous. In the annual meeting of the Royal College of Psychiatrists, he said that people who have active online activities are possibly giving less attention to their real lives | | The controversial anti-obestity drug rimonabant, marketed as Acomplia, has been approved for National Health Service (NHS) use in the England and Wales. The National Institute for Healthcare and Clinical Excellence (NICE) has approved use of this diet drug in people who are clinically obese or people who are seriously overweight with complications such as diabetes. The drug, made by Sanofi-Aventis, is approved for sale in Britain and elsewhere in the European Union but was rejected by a U.S. Food and Drug Administration panel in June 2007 because of concerns the drug increases the risk of depression and suicidal thoughts | | The number of elderly people who killed themselves in Japan surged in 2007 prompted by mounting health and economic worries, government figures showed. The deaths of elderly people helped push the country's overall number of suicides to 33,093 in 2007, a 2.9 percent increase and the second-highest annual tally on record since 1978, the National Police Agency said in a yearly report | | The Food and Drug Administration is very close to finalizing new suicide warnings for 11 anti-seizure medications after research showed they increased patients' risk of suicidal thoughts and behavior. In addition to treating epilepsy, the anti-seizure medications are also used for a variety of other illnesses, including migraines, certain nerve-pain disorders, and psychiatric diseases such as bipolar disorder that themselves carry a risk of suicide | |
|
|